Additionally, there are many excellent reviews about other mechanisms of CXCL8 in tumor therapy resistance (Alfaro et al., 2017; Cheng et al., 2019; Horn et al., 2020a; Fousek et al., 2021). The gene discussed is CXCL8; the disease is neoplasm.